Third generation oral contraceptives and risk of myocardial infarction: An international case-control study

British Medical Journal

Volumn 312, Issue 7023, 1996, Pages 88-90

  Lewis, Michael A ^b   Spitzer, Walter O ^a   Heinemann, Lothar A J ^b   MacRae, Kenneth D ^b   Bruppacher, Rudolf ^b   Thorogood, Margaret ^b  

^a ASTROPHYSIKALISCHES INSTITUT POTSDAM   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DESOGESTREL; GESTAGEN; GESTODENE; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT; SMOKING;

EID: 0029671040     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.312.7023.88     Document Type: Article

References (11)

1. Spitzer WO, Thorogood M, Heinemann L. Trinational case-control study of oral contraceptives and health. Pharmacoepidemiol Drug Saf 1993;2: 21-31.
2. Lewis MA, Assman A, Heinemann L, Spitzer WO. Transnational case-control study of oral contraceptives and health. Approved protocol Tensions to September 1995. Pharmacoepidemiol Drug Saf (in press).
3. Spitzer WO, Lewis MA, Heinemann LAJ, Thorogood M, MacRae KD. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. BMJ 1996;312:83-8.
4. Poulter N, et al. A multinational case-control study of cardiovascular disease and steroid hormone contraceptives. J Clin Epidemiol (in press).
5. Levin ML. The occurrence of lung cancer in man. Acta Unio Int Cancer 1953;9:531-41.
6. Cole P, McMahon B. Attributable risk percent in case control studies. Br J Prev Soc Med 1971;25:242-1.
7. Miettinen OS. Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol 1974;100:325-32.
8. Kjaer A, Lebech A-M, Borggaard B, Refn H, Pedersen LR, Schierup L, et al. Lipid metabolism and coagulation of two contraceptives: correlation to serum concentrations of levonogestrel and gestodene. Contraception 1989; 40:665-73.
9. Engel HJ, Engel K, Behnke K, Lichtlen P. Angiographische Befunde nach Herzinfarkt junger Frauen: die Rolle oraler Kontrazeptiva. Herz 1987;12: 290-5.
10. Thorogood M. Oral contraceptives and cardiovascular disease: an epidemiologic overview. Pharmacoepidemiol Drug Saf 1993;2:21-31.
11. Royal College of General Practitioners. Oral contraceptives and health. An interim report from the oral contraception study. London: Pitman Medical, 1974.